Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Buy Land Securities Group (LAND) by Jon Smith in The Motley Fool
- Buy Smith (DS) (SMDS) by Jon Smith in The Motley Fool
- Buy Greencoat UK Wind (UKW) by Royston Wild in The Motley Fool
- Buy Vistry Group (VTY) by Royston Wild in The Motley Fool
- Buy Computacenter (CCC) by Citi
- Sell Restaurant Group (RTN) by Lucian Miers in N50
- Buy MyHealthchecked (MHC) by Hot Stock Rockets in ShareProphets
- Buy British American Tobacco (BATS) by Christopher Ruane in The Motley Fool
- Buy Pershing Square Holdings Ltd NPV (PSH) by Jon Smith in The Motley Fool
- Hold Burberry Group (BRBY) by Chris Bailey in ShareProphets
- Hold GSK (GSK) by Chris Bailey in ShareProphets
- Buy Burberry Group (BRBY) by Stifel
- Outperform Frontier Developments (FDEV) by Credit Suisse
- Neutral Travis Perkins (TPK) by UBS
- Sell Hammerson (HMSO) by UBS
- Buy Smith & Nephew (SN.) by Christopher Ruane in The Motley Fool
- Hold BT Group (BT.A) by Edmond Jackson in Interactive Investor
- Add Somero Enterprises Inc. (DI) (SOM) by Zaven Boyrazian in The Motley Fool
- Hold Safestore Holdings (SAFE) by Jefferies
- Buy Taylor Wimpey (TW.) by Jefferies
Hikma Pharmaceuticals (HIK)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Jefferies | – | 2022-09-15 04:49:00 15/09/2022 | – |
| – | Zaven Boyrazian | – | 2022-09-01 08:05:00 01/09/2022 | – |
| – | Barclays | – | 2022-08-31 18:00:00 31/08/2022 | – |
| – | Zaven Boyrazian | – | 2022-08-22 07:15:00 22/08/2022 | – |
| – | JP Morgan | – | 2022-08-11 04:59:00 11/08/2022 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Jefferies | – | 2022-09-15 04:49:00 15/09/2022 | – |
| – | Zaven Boyrazian | – | 2022-09-01 08:05:00 01/09/2022 | – |
| – | Barclays | – | 2022-08-31 18:00:00 31/08/2022 | – |
| – | Zaven Boyrazian | – | 2022-08-22 07:15:00 22/08/2022 | – |
| – | JP Morgan | – | 2022-08-11 04:59:00 11/08/2022 | – |